SBFM Latest Press Releases

-- June 25, 2026 --

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) ACCESS Newswire 8:00 AM

-- June 1, 2026 --

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) ACCESS Newswire 8:00 AM

-- May 29, 2026 --

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology ACCESS Newswire 8:00 AM

-- May 28, 2026 --

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing ACCESS Newswire 9:00 AM

-- May 21, 2026 --

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin ACCESS Newswire 7:00 AM

-- May 19, 2026 --

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering ACCESS Newswire 12:08 PM

-- May 18, 2026 --

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering ACCESS Newswire 12:17 PM

-- April 6, 2026 --

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year ACCESS Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software